First Ever Clinical Trial of THC Confirms its Efficacy against Chronic Pain

Jul 6, 2020 by CenTrial



For the first time, a clinical trial has been able to confirm the efficacy of micro-dosing THC to treat chronic pain. 

A pharma-tech company in Israel, Syqe Medical, was able to surmount the problem of standardizing the cannabis dosage by inventing the Syqe Inhaler to precisely measure low-levels of THC.

The randomized, double-blinded, and placebo-controlled trial tested 27 subjects over three test days where they received either one inhaled 0.5mg  or 1mg dose of THC, or a placebo.

Significantly, both doses of THC demonstrated reductions in pain intensity that lasted up to 150 minutes and showed no signs of mental impairment.

"We can conclude from the study results that low doses of cannabis may provide desirable effects while avoiding cognitive debilitations, significantly contributing to daily functioning, quality of life, and safety of the patient,” says Elon Eisenberg, lead research on the project, from the Technion-Israel Institute of Technology. “The doses given in this study, being so low, mandate very high precision in the treatment modality.”

---